Pregnancy: Pregnancy category: B.
Cefixime crosses the placenta and can be detected in the amniotic fluid. No confirmation of safety for pregnant women. Cefixime should be administered to pregnant patients or women suspected of being pregnant, only if the expected therapeutic benefit is thought to outweigh any possible risk.
Lactation: It is not known if Cefixime is excreted into breast milk. Consideration is given to discontinuing nursing temporarily during treatment.